Law360, New York (January 11, 2018, 4:38 PM EST) — While certain claims in a Novartis AG patent for its immunosuppressant Zortress probably could have been found by other chemists based on existing knowledge, the chances were so small that the discovery deserves a patent, the Patent Trial and …
